Age and time need not and should not be eliminated from the coronary risk prediction models

Circulation

Volumn 111, Issue 5, 2005, Pages 542-545

  Vasan, Ramachandran S ^a,c   D'Agostino Sr , Ralph B ^a,b  

^a FRAMINGHAM HEART STUDY   (United States)

^b Boston University   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary disease; Editorials; Prevention; Prognosis; Risk factors

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; CORONARY RISK; EDITORIAL; FEMALE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MALE; MODEL; PERCEPTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; TIME;

ADULT; AGE FACTORS; ALGORITHMS; CORONARY DISEASE; FEMALE; HUMANS; MALE; MODELS, CARDIOVASCULAR; PRACTICE GUIDELINES; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; TIME FACTORS; UNITED STATES;

EID: 13444292829     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000156100.73739.B8     Document Type: Editorial

References (17)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560-2572.
3. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM; SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987-1003.
4. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomer K, Perk J, Pyorala K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D; Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003;24:1601-1610.
5. Ridker PM, Cook N. Should age and time be eliminated from cardiovascular risk prediction models? Rationale for the creation of a new national risk detection program. Circulation. 2005;111:657-658.
6. National Cholesterol Education Program. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Available at: http://nhlbi.nih.gov/guidelines/ cholesterol/atp3_rpt.htm. Accessed December 21, 2004.
7. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
8. National Cholesterol Education Program of the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute. Spreadsheet-based 10-year risk assessment tool. Available at: http://hin.nhlbi.nih.gov/atpiii/ riskcalc.htm. Accessed January 10, 2005.
9. National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. Bethesda, Md: National Heart, Lung, and Blood Institute; 1990. NIH publication 90-3046.
10. National Heart, Lung, and Blood Institute. Information for...Patients and the Public: Heart and Vascular Diseases: Available at: http://nhlbi.nih.gov/ health/public/heart. Accessed January 10, 2005.
11. Edwards A, Elwyn G. Understanding risk and lessons for clinical risk communication about treatment preferences. Qual Health Care. 2001;10:i9-i13.
12. Edwards A, Elwyn G, Mulley A. Explaining risks: turning numerical data into meaningful pictures. BMJ. 2002;324:827-830.
13. Epstein RM, Alper BS, Quill TE. Communicating evidence for participatory decision making. JAMA. 2004;291:2359-2366.
14. Hembroff LA, Holmes-Rovner M, Wills CE. Treatment decision-making and the form of risk communication: results of a factorial survey. BMC Med Inform Decis Mak. 2004;4:20.
15. Lloyd AJ. The extent of patients' understanding of the risk of treatments. Qual Health Care. 2001;10:i14-i18.
16. Skolbekken JA. Communicating the risk reduction achieved by cholesterol reducing drugs. BMJ. 1998;316:1956-1958.
17. Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation. 2003;107:2185-2189.